p.120 抽出テキスト

1059. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017;76:17–28. https://doi.org/10.1136/annrheumdis-2016- 209775 1060. Xie W, Huang H, Xiao S, Yang X, Zhang Z. Effect of statin use on cardiovascular events and all-cause mortality in immune-mediated inflammatory diseases: a systematic review and meta-analysis involving 148,722 participants. Pharmacol Res 2020;160: 105057. https://doi.org/10.1016/j.phrs.2020.105057 1061. Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, et al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis 2022;81:768–79. https://doi.org/10.1136/annrheumdis-2021-221733 1062. Rahmadi AR, Pranata R, Raffaello WM, Yonas E, Ramadhian MP, Natadikarta MRR, et al. The effect of statin on major adverse cardiovascular events and mortality in patients with rheumatoid arthritis—a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 2022;26:3171–8. https://doi.org/10.26355/eurrev_202205_28734 1063. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957–67. https://doi.org/10.1016/S0140- 6736(15)01225-8 1064. McEvoy JW, Touyz RM, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, et al. ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024. https://doi.org/10.1093/eurheartj/ehae178 1065. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39: 3021–104. https://doi.org/10.1093/eurheartj/ehy339 1066. Suwalski P, Kowalewski M, Jasiński M, Staromłyński J, Zembala M, Widenka K, et al. Surgical ablation for atrial fibrillation during isolated coronary artery bypass surgery. Eur J Cardiothorac Surg 2020;57:691–700. https://doi.org/10.1093/ejcts/ezz298 1067. Van Gelder IC, Kotecha D, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, et al. 2024 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2024. https://doi.org/10.1093/eurheartj/ehae176 1068. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/ EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022;43: 561–632. https://doi.org/10.1093/eurheartj/ehab395 1069. Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol 2015;26:2504–11. https://doi.org/10.1681/asn.2014070714 1070. Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 2019;74:1823–38. https://doi.org/10.1016/j.jacc.2019.08.1017 1071. Konstantinidis I, Nadkarni GN, Yacoub R, Saha A, Simoes P, Parikh CR, et al. Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review. JAMA Intern Med 2016;176:121–4. https://doi. org/10.1001/jamainternmed.2015.6102 1072. Morales J, Handelsman Y. Cardiovascular outcomes in patients with diabetes and kidney disease: JACC review topic of the week. J Am Coll Cardiol 2023;82:161–70. https:// doi.org/10.1016/j.jacc.2023.04.052 1073. Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med 2019;380:2146–55. https://doi.org/10.1056/NEJMra1805256 1074. Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, et al. Management of coronary disease in patients with advanced kidney disease. N Engl J Med 2020;382: 1608–18. https://doi.org/10.1056/NEJMoa1915925 1075. Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Revascularization in patients with multivessel coronary artery disease and chronic kidney disease: everolimus-eluting stents versus coronary artery bypass graft surgery. J Am Coll Cardiol 2015;66:1209–20. https://doi.org/10.1016/j.jacc.2015.06.1334 1076. Wang Y, Zhu S, Gao P, Zhang Q. Comparison of coronary artery bypass grafting and drug-eluting stents in patients with chronic kidney disease and multivessel disease: a meta-analysis. Eur J Intern Med 2017;43:28–35. https://doi.org/10.1016/j.ejim.2017.04. 002 1077. Raposeiras-Roubin S, Abu-Assi E, Munoz-Pousa I, Rossello X, Cespón-Fernández M, Melendo Viu M, et al. Usefulness of bleeding after acute coronary syndromes for unmasking silent cancer. Am J Cardiol 2020;125:1801–8. https://doi.org/10.1016/j. amjcard.2020.03.023 1078. Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022;43:4229–361. https://doi.org/10.1093/eurheartj/ehac244 1079. Falanga A, Leader A, Ambaglio C, Bagoly Z, Castaman G, Elalamy I, et al. EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer. Hemasphere 2022;6:e750. https://doi.org/10.1097/hs9.000000000000 0750 1080. Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation 2018;138:1100–12. https://doi.org/10.1161/circulationaha. 117.033369 1081. Lee D. HIV: how to manage dyslipidaemia in HIV. Drugs Context 2022;11:2021-8-7. https://doi.org/10.7573/dic.2021-8-7 1082. Dekkers CC, Westerink J, Hoepelman AIM, Arends JE. Overcoming obstacles in lipid-lowering therapy in patients with HIV—a systematic review of current evidence. AIDS Rev 2018;20:205–19. https://doi.org/10.24875/AIDSRev.18000016 1083. Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association. Circulation 2019;140:e98–124. https://doi.org/10.1161/cir.0000000000000695 1084. Foster HME, Celis-Morales CA, Nicholl BI, Petermann-Rocha F, Pell JP, Gill JMR, et al. The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort. Lancet Public Health 2018;3:e576–85. https://doi.org/ 10.1016/s2468-2667(18)30200-7 1085. Floud S, Balkwill A, Moser K, Reeves GK, Green J, Beral V, et al. The role of health-related behavioural factors in accounting for inequalities in coronary heart disease risk by education and area deprivation: prospective study of 1.2 million UK women. BMC Med 2016;14:145. https://doi.org/10.1186/s12916-016-0687-2 1086. Stringhini S, Carmeli C, Jokela M, Avendaño M, Muennig P, Guida F, et al. Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women. Lancet 2017;389:1229–37. https://doi.org/10.1016/s0140-6736(16)32380-7 1087. Di Girolamo C, Nusselder WJ, Bopp M, Brønnum-Hansen H, Costa G, Kovács K, et al. Progress in reducing inequalities in cardiovascular disease mortality in Europe. Heart 2020;106:40–9. https://doi.org/10.1136/heartjnl-2019-315129 1088. Leyland AH, Dundas R. Declining cardiovascular mortality masks unpalatable inequalities. Heart 2020;106:6–7. https://doi.org/10.1136/heartjnl-2019-315708 1089. Sidhu GS, Ward C, Ferdinand KC. Racial disparity in atherosclerotic cardiovascular disease in hospitalized patients with diabetes 2005–2015: potential warning signs for future U.S. public health. Am J Prev Cardiol 2020;4:100095. https://doi.org/10. 1016/j.ajpc.2020.100095 1090. Pursnani S, Merchant M. South Asian ethnicity as a risk factor for coronary heart disease. Atherosclerosis 2020;315:126–30. https://doi.org/10.1016/j.atherosclerosis. 2020.10.007 1091. Patel AP, Wang M, Kartoun U, Ng K, Khera AV. Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK Biobank Prospective Cohort Study. Circulation 2021;144: 410–22. https://doi.org/10.1161/circulationaha.120.052430 1092. Hosseini F, Malhi N, Sellers SL, Khan N, Li CK, Taylor CM, et al. The morphology of coronary artery disease in South Asians vs white Caucasians and its implications. Can J Cardiol 2022;38:1570–9. https://doi.org/10.1016/j.cjca.2022.05.005 1093. Magavern EF, Jacobs B, Warren H, Finocchiaro G, Finer S, van Heel DA, et al. CYP2C19 genotype prevalence and association with recurrent myocardial infarction in British-South Asians treated with clopidogrel. JACC Adv 2023;2:100573. https://doi. org/10.1016/j.jacadv.2023.100573 1094. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942–4. https://doi.org/10.1016/ s0140-6736(02)11032-4 1095. Boardman HM, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;3:CD002229. https://doi.org/10.1002/14651858. CD002229.pub4 1096. Gili S, Grosso Marra W, D’Ascenzo F, Lonni E, Calcagno A, Cannillo M, et al. Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis. Eur Heart J 2016;37:3600–9. https://doi.org/10.1093/eurheartj/ehv734 1097. Bergström G, Persson M, Adiels M, Björnson E, Bonander C, Ahlström H, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation 2021;144:916–29. https://doi.org/10.1161/circulationaha.121.055340 1098. Nasir K, Cainzos-Achirica M, Valero-Elizondo J, Ali SS, Havistin R, Lakshman S, et al. Coronary atherosclerosis in an asymptomatic U.S. population: Miami Heart Study at Baptist Health South Florida. JACC Cardiovasc Imaging 2022;15:1604–18. https://doi. org/10.1016/j.jcmg.2022.03.010 1099. Baber U, Mehran R, Sartori S, Schoos MM, Sillesen H, Muntendam P, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol 2015;65:1065–74. https://doi.org/10.1016/j.jacc.2015.01.017 1100. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006;113:30–7. https://doi.org/10.1161/ circulationaha.105.580696 Downloaded from academic.oup.com/eurheartj/article/45/36/3415/7743115 by guest on 07 October 2026